May 22, 2025

New FDA-Approved Topical Foam for Scalp Psoriasis

The FDA has approved roflumilast (ZORYVE) foam 0.3% for once-daily treatment of plaque psoriasis in patients aged 12 and older, including hard-to-treat scalp and body areas..

Conexiant

May 22, 2025

FDA to Rethink COVID Booster Formula

FDA advisers to vote on whether 2025–2026 COVID vaccines should target JN.1 descendants like LP.8.1 amid rising uncertainty over dominant strains.

Reuters

May 22, 2025

Dual Inhaler Halves Mild Asthma Attacks in Trial

As-needed albuterol-budesonide was superior to albuterol alone for mild, uncontrolled asthma in new trial.

Conexiant

May 21, 2025

New Biomarkers for Ultraprocessed Food Intake

NCI researchers identified blood and urine metabolite patterns that objectively measure ultraprocessed food consumption.

Conexiant

May 20, 2025

New Noninvasive Option for Functional Abdominal Pain

The FDA has cleared IB-Stim as the first treatment specifically indicated for pediatric functional dyspepsia and related nausea, providing a noninvasive neuromodulation option for abdominal pain in patients aged 8 to 21 years.

Conexiant

May 20, 2025

New COVID Shot: LP.8.1?

FDA advisers to consider recommending COVID-19 vaccine for 2025-2026 season to target LP.8.1 subvariant.

Reuters

May 20, 2025

No Trials, No Boosters, Says FDA

FDA to require new clinical trials for COVID booster approval in healthy Americans under 65, limiting fall availability to high-risk groups.

Reuters

May 20, 2025

Creamy, Dreamy, and Possibly Dangerous

Emulsifiers keep foods creamy—but at what cost?

KFF Health News

May 20, 2025

FDA Releases Guidance to Accelerate Generic Drugs

The new guidance is intended to “foster drug product development, ANDA submission and approval, and ultimately provide increased access to generic drugs."

Conexiant